[Retracted] Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department

Table 1

Characteristics of patients in the DeCi cohort.

Variable	Patients with decompensated cirrhosis ()
Sex (male), (%)	344 (75.4%)
Age, median (IQR)	53.5 (46-63.75)
Hospitalization days, median (IQR)	11 (9-13)
Intensive care unit (%)	64 (14.0%)
Cause of liver cirrhosis, (%)
Viral	276 (60.5%)
Alcoholic	72 (15.8)
Combined alcoholic viral	37 (8.1%)
Other	28 (6.1%)
Cryptogenic	43 (9.4%)
Cause of hospitalization, (%)
Ascites	3 (0.7%)
Gastrointestinal hemorrhage	407 (89.2%)
Hepatic encephalopathy	22 (4.8%)
Infection	24 (5.3%)
Ascites degree, (%)
No ascites	195 (42.8%)
1st-degree ascites	123 (27.0%)
2nd-degree ascites	80 (17.5%)
3rd-degree ascites	58 (12.7%)
Renal failure, (%)	20 (4.4%)
Hepatocellular carcinoma, (%)	56 (12.3%)
Acute decompensation, (%)	436 (95.5%)
Therapy, (%)
Vasopressor support	144 (31.6%)
Mechanical ventilation	27 (5.9%)
Renal replacement therapy	2 (4.4%)
28-day outcome, (%)
Lost to follow-up	31 (6.8%)
Survivors	375 (82.2%)
Nonsurvivors	50 (11.0%)
90-day outcome, (%)
Lost to follow-up	77 (16.9%)
Survivors	300 (65.8%)
Nonsurvivors	76 (16.6%)
6-month outcome, (%)
Lost to follow-up	132 (28.9%)
Survivors	233 (51.1%)
Nonsurvivors	91 (19.9%)

IQR: interquartile range.